Loading
Neurological Complications and Syndromes · Journal article
Cephalalgia · August 1, 2026
A consensus or society position rather than new primary data.
This factsheet synthesises current evidence on the epidemiology, burden, and management of migraine and headache disorders in children and adolescents, drawing on GBD 2023 estimates and published systematic reviews. It documents substantial prevalence (10.71–42.64% for all headache; 2.79–18.08% for migraine), significant functional impairment, and inequitable access to diagnosis and treatment, particularly in low- and middle-income countries.
Systematic evidence synthesis and factsheet. Children and adolescents aged 5–19 years; global population-based estimates and published literature. Global.
Headache disorder prevalence increases from 10.71% (ages 5–9 years) to 42.64% (ages 15–19 years) Migraine prevalence increases from 2.79% (ages 5–9 years) to 18.08% (ages 15–19 years) per GBD 2023 Migraine is among leading causes of years lived with disability from early life onwards
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and policymakers should recognise migraine and headache as major sources of childhood and adolescent disability with clear developmental progression. Early, equitable, developmentally tailored intervention during adolescence may reduce progression to chronic migraine and long-term disability, particularly in under-resourced settings.
A comprehensive, evidence-based factsheet synthesising population studies, systematic reviews, and GBD 2023 data to inform clinical and policy understanding of paediatric headache burden and management priorities.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and policymakers should recognise migraine and headache as major sources of childhood and adolescent disability with clear developmental progression. Early, equitable, developmentally tailored intervention during adolescence may reduce progression to chronic migraine and long-term disability, particularly in under-resourced settings.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
BackgroundHeadache disorders, particularly migraine, are among the leading causes of disability worldwide, with onset frequently occurring during childhood and adolescence. Despite their high prevalence and substantial functional impact, paediatric headache disorders remain under-recognised within health systems and under-represented in global policy frameworks.MethodsThis factsheet was developed to provide a comprehensive, developmentally informed overview of the global burden of headache disorders in children and adolescents. It synthesises evidence from population-based studies, systematic reviews, clinical cohorts, and Global Burden of Disease (GBD) 2023 estimates. Key domains include epidemiology, disability burden, functional and psychosocial impacts, risk factors and triggers, diagnostic and treatment gaps, and current management strategies, with particular attention to disparities across sociodemographic groups.ResultsAccording to GBD 2023 point-prevalence estimates, headache disorders increase markedly across development, from 10.71% among children aged 5-9 years to 42.64% among adolescents aged 15-19 years. Corresponding migraine prevalence estimates increase from 2.79% to 18.08%. GBD 2023 data also indicate that migraine is among the leading causes of years lived with disability from early life onwards.Migraine in children and adolescents is associated with substantial impairment in school attendance, academic performance, social participation, and quality of life. It is also frequently accompanied by psychiatric and somatic comorbidities. Access to timely diagnosis and evidence-based treatment remains highly inequitable, particularly in low- and middle-income countries. Emerging evidence suggests that adolescence may represent a critical window for intervention, with the potential to reduce progression to chronic migraine and long-term disability.ConclusionsMigraine and other headache disorders in children and adolescents constitute a major global public health challenge. This factsheet provides a comprehensive, evidence-based summary of their burden and highlights urgent priorities for policy integration, advocacy, and research. Early, equitable, and developmentally tailored care is essential to reduce lifelong disability and improve global brain health outcomes.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.